Cancer chemotherapy is the use of drugs to kill cancer cells. Unlike radiation and surgery, which are localized treatments, chemotherapy is a systemic treatment, meaning the drugs travel throughout the whole body. This means chemotherapy can reach cancer cells that may have spread, or metastasized, to other areas.
Chemotherapy is usually combined with other types of treatment (surgery, radiation therapy) in an attempt to do the following:
- Cure smaller, early-stage pancreatic cancer
- Increase survival time in more advanced pancreatic cancer (Although, this usually means only by a matter of months.)
- Provide some symptom relief
Chemotherapy Drugs Used for Pancreatic Cancer
- Fluorouracil (5-FU)
- Gemcitabine (the first line treatment)
- Gemcitabine plus erlotinib (Tarceva)—first line treatment
- Cisplatin (Blastolem RU, Tecnoplatin)
- Investigational agents (experimental treatments)
- Streptozotocin (for endocrine tumors)
Gemcitabine, used alone or in combination with other chemotherapy agents, seems to improve the quality of life for patients with pancreatic cancer. Chemotherapy with gemcitabine improves symptoms, including pain, nausea, and vomiting in about 25% of patients. It also provides a modest increase in survival (usually only a few months).
Fluorouracil is not associated with a survival benefit. Cisplatin and some other drugs have been used in combination with gemcitabine, but are associated with more side effects.
These drugs should be used with caution in the elderly and those with liver or kidney disease . Elderly patients are at an increased risk of side effects.
- Reviewer: Mohei Abouzied, MD, FACP
- Review Date: 09/2014 -
- Update Date: 09/17/2014 -